The 2018 Virginia Ebola & Highly Infectious Disease Summit will be held Nov. 19, 2018 in Winchester, Virginia. Highlighted presentations include: From Ebola to Emerging Infectious Diseases: A Focus on the Frontlines [Read more]
The Centers for Disease Control and Prevention (CDC) operates high-containment laboratories (HCLs) to study some of the most virulent threats to public health. Outbreaks involving pathogens such as the Ebola and Zika [Read more]
The U.S. Army for Medical Research Institute of Infectious Diseases (USAMRIID) has suspended Biosafety Level 3 (BSL-3) and Biosafety Level 4 (BSL-4) operations while conducting repairs to its waste treatment plant. Unprecedented [Read more]
The National Institute of Allergy and Infectious Diseases (NIAID) Integrated Research Facility (IRF) is part of the National Interagency Biodefense Campus based at Fort Detrick, Maryland. Under a new contract worth up [Read more]
See what we’re reading this week at Global Biodefense on topics including the Pandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPAI); investigating shipment of chemical weapon components to Syria; and safely regulating the [Read more]
Following the October 2001 confirmation of anthrax in official government mail, a series of screening processes were implemented to safeguard the Pentagon and other Pentagon delegated facilities from biological hazards that might [Read more]
Biosecurity professionals from across the U.S. and Mexico gathered on Arizona State University’s Tempe campus Dec. 7 and 8 to discuss multidisciplinary approaches and perspectives on biosecurity. The two-day Arizona Biosecurity Workshop [Read more]
The Defense Advanced Research Projects Agency Biological Technologies Office (DARPA BTO) is currently accepting proposals under its streamlined funding process, the Biological Technologies EZ Broad Agency Announcement (EZ BAA). DARPA BTO seeks [Read more]
The Defense Biological Product Assurance Office (DBPAO), a component of the Joint Program Executive Office for Chemical and Biological Defense, has announced the development of a Biological Select Agents and Toxins (BSAT) [Read more]
By Kathryn Insley Biological agents including viruses, bacteria, and toxins, can devastate local economies with their potential effects on humans and livestock. In addition to potentially catastrophic immediate impact, these agents could also [Read more]
© 2019 STEMAR MEDIA